Fragile X Syndrome Testing and the Limitations Associated with Current Maternal Cell Contamination Testing Strategies

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 17, Issue 11

Abstract

Aims: To assess the level of maternal cell contamination (MCC) that can be detected in the molecular determination of triplet repeat expansions in the FMR1 gene. Place and Duration of Study: Department of Diagnostic Genetics, LabPLUS, Auckland City Hospital, Auckland, New Zealand, between June 2013 and July 2015. Methodology: We assessed the sensitivity of a fluorescence-based assay for determining the number of CGG repeats in the FMR1 gene in a simulated MCC using spiked samples of known concentrations. This assay was applied to a prenatal case to resolve the question as to whether the CGG alleles detected in the fetal sample were inherited or due to MCC. Results: The simulated MCC study showed that detection levels range from 0.5% to as low as 0.1%. Conclusion: Collectively, our data support the view that future MCC guidelines should address the need for increased MCC testing sensitivity to accompany Fragile X syndrome prenatal testing.

Authors and Affiliations

Philippa A. Dryland, Annet Damhuis, Douglas I. Rosendale, Kimberley Hughes, Elaine Doherty, Donald R. Love

Keywords

Related Articles

Dyslipidemia in HIV Infected Children and Adolescents on Highly Active Antiretroviral Therapy in Abuja, Nigeria

Background: Compelling evidence exists on the usefulness of highly active antiretroviral therapy in the improvement of life of people living with HIV. There is however growing concern from its prolong exposure in childre...

Urinary Tract Infection in Children

We selected the pediatric urinary tract infection related research and review articles in English language using keywords or phrases such as Infant; children; culture; Escherichia coli; fever, UTI. Aims: The purpose of t...

Case Study: Magnetic Resonance Imaging of Squamous Cell Carcinoma of Perianal Region, Vulva and Cervix

Squamous cell carcinoma is the second most common skin carcinoma, which most commonly affects sun-exposed areas. However squamous cell carcinoma can rarely involve the anal and perianal region. It has been found in assoc...

Fragile X Syndrome Testing and the Limitations Associated with Current Maternal Cell Contamination Testing Strategies

Aims: To assess the level of maternal cell contamination (MCC) that can be detected in the molecular determination of triplet repeat expansions in the FMR1 gene. Place and Duration of Study: Department of Diagnostic Gene...

A Qualitative Content Analysis of Breast Cancer Narratives Hosted Through the Medium of Social Media

Aims: Social media and networking host a significant amount of breast cancer related information. Breast cancer accounts for the largest number of new internet postings amongst the top four cancers. The objective of this...

Download PDF file
  • EP ID EP341534
  • DOI 10.9734/BJMMR/2016/28769
  • Views 82
  • Downloads 0

How To Cite

Philippa A. Dryland, Annet Damhuis, Douglas I. Rosendale, Kimberley Hughes, Elaine Doherty, Donald R. Love (2016). Fragile X Syndrome Testing and the Limitations Associated with Current Maternal Cell Contamination Testing Strategies. Journal of Advances in Medicine and Medical Research, 17(11), 1-7. https://europub.co.uk/articles/-A-341534